The effect of tapinarof in psoriasis is related to the activation of the aryl hydrocarbon receptor (AhR), a ligand-dependent transcription factor that regulates gene expression in a variety of cells, including immune and epithelial cells. This evidence concerns the gene AHR and psoriasis.